September 06, 2005   Solvay Pharmaceuticals launches DUODOPA® in 12 new European countries
Solvay Pharmaceuticals launches DUODOPA® – its treatment for advanced Parkinson’s disease – in 12 new European countries

August 02, 2005   Solvay and Berna Biotech sign a license agreement for Aerugen®
Solvay Pharmaceuticals and Berna Biotech Ltd announce today that they have signed a commercialization and license agreement for Aerugen®, a vaccine for the prevention of Pseudomonas aeruginosa (PA) infection in Cystic Fibrosis (CF) patients.